TRIMTAC
LIVE

Serial Number

79445800

Owner

TRIMTECH Therapeutics Limited

Filing Date

Jan 30, 2026

Add to watchlist:

No watchlists yet
View on USPTO

TRIMTAC Trademark

Serial Number: 79445800

TRIMTAC is a trademark filed by TRIMTECH Therapeutics Limited on January 30, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

TRIMTECH Therapeutics Limited (5 trademarks)

22 Station Road,

Entity Type: 99

Trademark Details

Filing Date

January 30, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical and medical preparations and substances; preparations for use in targeted and personalized pharmaceutical therapies; pharmaceutical preparations and substances for the treatment of diseases, including neurological, neurodegenerative, inflammatory and oncological diseases; biopharmaceuticals for the treatment of diseases, including neurological, neurodegenerative, inflammatory and oncological diseases; drugs for medical purposes; oral drugs for medical purposes; drugs for medical use for the degradation of toxins; pharmaceutical preparations in the fields of medicine, health, neurology, neurodegenerative diseases, inflammatory diseases, oncology, microorganisms and cells; biological preparations for medical purposes; biological compounds for use in targeted and personalized pharmaceutical therapies; proteins, reagents and cultures, all for medical purposes; proteins with diagnostic and therapeutic uses; drug delivery agents that facilitate the delivery of pharmaceutical preparations; diagnostic test kits for medical purposes.

Drug development services; scientific consultancy; laboratory services; provision of information and data relating to medical research and development; medical and pharmacological research and development services; scientific research; biochemical and biological research; clinical research; laboratory research; research and development services in the field of medical therapeutics, including in the fields of neurology, neurodegenerative diseases, inflammatory diseases, oncology, microorganisms and cells; research and development services in the field of drug development, protein testing, and degradation of aggregated proteins; research, development and design of scientific and medical testing and screening products; scientific testing services; biological testing; information, consultancy and advisory services relating to the aforesaid.

Filing History

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 30, 2026 RFCR
NON-FINAL ACTION WRITTEN
May 29, 2026 CNRT
ASSIGNED TO EXAMINER
May 28, 2026 DOCK
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 14, 2026 ADCH
APPLICATION FILING RECEIPT MAILED
Mar 16, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 12, 2026 REPR